BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21170416)

  • 1. Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling.
    Saraswati S; Alfaro MP; Thorne CA; Atkinson J; Lee E; Young PP
    PLoS One; 2010 Nov; 5(11):e15521. PubMed ID: 21170416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α.
    Thorne CA; Hanson AJ; Schneider J; Tahinci E; Orton D; Cselenyi CS; Jernigan KK; Meyers KC; Hang BI; Waterson AG; Kim K; Melancon B; Ghidu VP; Sulikowski GA; LaFleur B; Salic A; Lee LA; Miller DM; Lee E
    Nat Chem Biol; 2010 Nov; 6(11):829-36. PubMed ID: 20890287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrvinium, a potent small molecule Wnt inhibitor, increases engraftment and inhibits lineage commitment of mesenchymal stem cells (MSCs).
    Saraswati S; Deskins DL; Holt GE; Young PP
    Wound Repair Regen; 2012; 20(2):185-93. PubMed ID: 22332749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
    Cui L; Zhao J; Liu J
    Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction.
    Yang D; Fu W; Li L; Xia X; Liao Q; Yue R; Chen H; Chen X; An S; Zeng C; Wang WE
    Clin Sci (Lond); 2017 Dec; 131(24):2919-2932. PubMed ID: 29162747
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Lin L; Xu W; Li Y; Zhu P; Yuan W; Liu M; Shi Y; Chen Y; Liang J; Chen J; Yang B; Cai W; Wen Y; Zhu X; Peng X; Zhou Z; Mo X; Wan Y; Yuan H; Li F; Ye X; Jiang Z; Wang Y; Zhuang J; Fan X; Wu X
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1634-H1645. PubMed ID: 33635162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
    Zhang C; Zhang Z; Zhang S; Wang W; Hu P
    Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CK1α Activator Pyrvinium Enhances the Catalytic Efficiency (
    Shen C; Li B; Astudillo L; Deutscher MP; Cobb MH; Capobianco AJ; Lee E; Robbins DJ
    Biochemistry; 2019 Dec; 58(51):5102-5106. PubMed ID: 31820934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development.
    Bergmann MW
    Circ Res; 2010 Nov; 107(10):1198-208. PubMed ID: 21071717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.
    Zheng L; Liu Y; Pan J
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):890-898. PubMed ID: 28981601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein kinase 1α-dependent inhibition of Wnt/β-catenin selectively targets nasopharyngeal carcinoma and increases chemosensitivity.
    Li J; Jiang Y; Wang P; Ke S; Yang L; Shen Y
    Anticancer Drugs; 2019 Aug; 30(7):e0747. PubMed ID: 31305293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrvinium attenuates Hedgehog signaling downstream of smoothened.
    Li B; Fei DL; Flaveny CA; Dahmane N; Baubet V; Wang Z; Bai F; Pei XH; Rodriguez-Blanco J; Hang B; Orton D; Han L; Wang B; Capobianco AJ; Lee E; Robbins DJ
    Cancer Res; 2014 Sep; 74(17):4811-21. PubMed ID: 24994715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Casein kinase 1α agonist pyrvinium attenuates Wnt-mediated CK1α degradation via interaction with the E3 ubiquitin ligase component Cereblon.
    Shen C; Nayak A; Neitzel LR; Yang F; Li B; Williams CH; Hong CC; Ahmed Y; Lee E; Robbins DJ
    J Biol Chem; 2022 Aug; 298(8):102227. PubMed ID: 35780831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.
    Bjorklund CC; Ma W; Wang ZQ; Davis RE; Kuhn DJ; Kornblau SM; Wang M; Shah JJ; Orlowski RZ
    J Biol Chem; 2011 Apr; 286(13):11009-20. PubMed ID: 21189262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.
    Li B; Orton D; Neitzel LR; Astudillo L; Shen C; Long J; Chen X; Kirkbride KC; Doundoulakis T; Guerra ML; Zaias J; Fei DL; Rodriguez-Blanco J; Thorne C; Wang Z; Jin K; Nguyen DM; Sands LR; Marchetti F; Abreu MT; Cobb MH; Capobianco AJ; Lee E; Robbins DJ
    Sci Signal; 2017 Jun; 10(485):. PubMed ID: 28655862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.
    Kim MS; Yoon SK; Bollig F; Kitagaki J; Hur W; Whye NJ; Wu YP; Rivera MN; Park JY; Kim HS; Malik K; Bell DW; Englert C; Perantoni AO; Lee SB
    J Biol Chem; 2010 May; 285(19):14585-93. PubMed ID: 20220130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovering small molecules as Wnt inhibitors that promote heart regeneration and injury repair.
    Xie S; Fu W; Yu G; Hu X; Lai KS; Peng X; Zhou Y; Zhu X; Christov P; Sawyer L; Ni TT; Sulikowski GA; Yang Z; Lee E; Zeng C; Wang WE; Zhong TP
    J Mol Cell Biol; 2020 Jan; 12(1):42-54. PubMed ID: 30925593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin.
    Cselenyi CS; Jernigan KK; Tahinci E; Thorne CA; Lee LA; Lee E
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8032-7. PubMed ID: 18509060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.